title: Gefitinib Plus Pemetrexed As First-Line Treatment in Patients With Nonsquamous Non-Small-Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations.
authors.affiliation: Young Hak Kim, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
authors.forename: Young Hak
authors.initials: YH
authors.lastname: Kim
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung; D066246:ErbB Receptors / Q000235:genetics; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms; D009154:Mutation; D000068437:Pemetrexed
chemical_list: D000068437:Pemetrexed; D066246:ErbB Receptors; D000077156:Gefitinib